Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06950424 · ClinicalTrials.gov registry record · NA
Effect of Black Cumin Seed Oil Supplementation on Cortisol, Stress and Mood
A NA study of Stress and Mood, sponsored by Shawn Talbott.
- Active
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06950424: Active NA study of Stress and Mood, sponsored by Shawn Talbott.
NCT06950424 is a NA study of Stress and Mood that is active but no longer recruiting, run by Shawn Talbott. The registered enrollment target is 40 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06950424, a NA study of Stress and Mood, is active but no longer recruiting, sponsored by Shawn Talbott.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study will be to collect data to support the role of black cumin seed oil, also known as black seed oil (BSO), in moderating the stress response, including objective markers of stress (cortisol/DHEA) as well as subjective measures (mood/stress/sleep/beauty). The primary outcomes will be salivary cortisol, subjective stress, and psychological vigor. Subjects will be recruited from among the clients of the Certified Mental Wellness Coaches (CMWCs) that have passed the digital badge course via Marietta College (https://www.credly.com/org/marietta-college/badge/certified-mental-wellness-coach-cmwc-online). If volunteers meet the inclusion/exclusion criteria, they will review/sign the Informed Consent Form (ICF - attached) before any Baseline measurements are collected. Because BSO is already known to deliver a wide range of potential health benefits, including anti-inflammatory, anti-oxidant, anti-diabetic, and immune-modulating effects - we expect to observe improvements on both subjective psychological and objective biochemical measures. Our primary outcome measures will be salivary cortisol and psychological mood state (POMS, including tension, mood, irritability, focus, fatigue, vigor and well-being).
Primary Outcome
measures of salivary cortisol
Interventions
- DIETARY_SUPPLEMENT black cumin seed oil
Study Locations (1)
Massachusetts
- 3 Waves Wellness - Plymouth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2025-10-01 |
| Phase | NA |
What the registry record for NCT06950424 still lists
NCT06950424 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 786-participant average among 152 other Stress trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Stress appearing as the primary indexed condition, and to 1 intervention - of which black cumin seed oil is the first listed.
NCT06950424 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06950424 about?
NCT06950424 is a clinical study titled "Effect of Black Cumin Seed Oil Supplementation on Cortisol, Stress and Mood". The primary objective of this study will be to collect data to support the role of black cumin seed oil, also known as black seed oil (BSO), in moderating the stress response, including objective markers of stress (cortisol/DHEA) as well as subjective measures (mood/stress/sleep/beauty). The primary...
What is the current status of trial NCT06950424?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-04-01. Estimated completion is 2025-10-01.
What conditions does trial NCT06950424 study?
This clinical trial studies the following conditions: Stress, Mood.
What interventions are being tested in trial NCT06950424?
The interventions under investigation include: black cumin seed oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06950424?
This trial is sponsored by Shawn Talbott, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06950424 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06950424's enrollment target sits among peer trials
40 117th of 152 higher than 31 of 152 other Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE)
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
ACT for HIV-Positive Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI